Human Milk Oligosaccharides Market By Type By Applications By Product By End User By Region Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast 2018 To 2026
The analysts of Healthcare Intelligence Markets have thoroughly examined the Global Human Milk Oligosaccharides (HMO) Market and have anticipated that the market will grow at a CAGR of +12% during the forecast period.
Human Milk Oligosaccharides (HMO) is a multifaceted bioactive sugar molecule present in human milk. It functions as an evolution substrate for specific valuable bacteria. As it is anatomically composite and varied, extracting or manufacturing them to use in the formula is a challenging task. As human milk oligosaccharides (HMO) is advantageous for micro biome and immunity, hence, numerous new procedures are getting explored and advanced by the key players, which include extracting HMO from cow milk, practicing exclusive methods or using microbes to produce them.
For Sample Copy of This Report : https://www.healthcareintelligencemarkets.com/request_sample.php?id=29056
Human milk oligosaccharides has been a major part of the infant diet, which prevents as well as cures diseases. This is one of the major factor that is driving the growth of the market tremendously.
The Human Milk Oligosaccharides (HMO) Market provides its segmentations by type such as 2’FL, 3’FL, 3’SL and 6’SL. Along with this, it also provides an in-depth analysis of the prominent factors that influence the market which includes drivers, opportunities, trends and industry-specific challenges.
Some of the players operating in the human milk oligosaccharides (HMO) market are Abbott, Inbiose, Company two, Jennewein Biotechnologie, Glycom, ZuChem, Dextra Laboratories among the others.
Abbott provides the 2′-FL HMO, or 2′-fucosyllactose human milk oligosaccharide, which is a prebiotic found naturally in breast milk. Around 80 percent of mothers make 2′-FL in their breast milk. Excluding water, HMOs are the third most abundant ingredient in breast milk after fat and carbohydrates.
The human milk oligosaccharides (HMO) market is anticipated to experience investments in the forthcoming years due to the shift in lifestyles that focuses more towards nutritious food, which is eventually driving the growth of the market. However, it has been seen that many manufacturers such chemical and enzymatic synthesis for manufacturing human milk oligosaccharides, which eventually have a low raw material availability and thus, this is restraining the progress of the market. But, as HMO abides prebiotic properties, ability to enhance memory and brain, which is likely to propel the market in the near future.
Avail Discount on this report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29056
• By Type
• By Applications
o Infant Formulas
o Health Ingredients for Human and Animal
o Food & Beverages
o Food Supplements
• By Product
• By End User
o Food Industry
o Laboratory Research
• By Region
o North America
o Asia Pacific
o South America
o Middle East & Africa